| First Author | Qian G | Year | 2024 |
| Journal | Am J Pathol | Volume | 194 |
| Issue | 4 | Pages | 599-611 |
| PubMed ID | 37838011 | Mgi Jnum | J:367879 |
| Mgi Id | MGI:7615801 | Doi | 10.1016/j.ajpath.2023.09.015 |
| Citation | Qian G, et al. (2024) DOCK2 Promotes Atherosclerosis by Mediating the Endothelial Cell Inflammatory Response. Am J Pathol 194(4):599-611 |
| abstractText | The pathology of atherosclerosis, a leading cause of mortality in patients with cardiovascular disease, involves inflammatory phenotypic changes in vascular endothelial cells. This study explored the role of the dedicator of cytokinesis (DOCK)-2 protein in atherosclerosis. Mice with deficiencies in low-density lipoprotein receptor and Dock2 (Ldlr(-/-)Dock2(-/-)) and controls (Ldlr(-/-)) were fed a high-fat diet (HFD) to induce atherosclerosis. In controls, Dock2 was increased in atherosclerotic lesions, with increased intercellular adhesion molecule (Icam)-1 and vascular cell adhesion molecule (Vcam)-1, after HFD for 4 weeks. Ldlr(-/-)Dock2(-/-) mice exhibited significantly decreased oil red O staining in both aortic roots and aortas compared to that in controls after HFD for 12 weeks. In control mice and in humans, Dock2 was highly expressed in the ECs of atherosclerotic lesions. Dock2 deficiency was associated with attenuation of Icam-1, Vcam-1, and monocyte chemoattractant protein (Mcp)-1 in the aortic roots of mice fed HFD. Findings in human vascular ECs in vitro suggested that DOCK2 was required in TNF-alpha-mediated expression of ICAM-1/VCAM-1/MCP-1. DOCK2 knockdown was associated with attenuated NF-kappaB phosphorylation with TNF-alpha, partially accounting for DOCK2-mediated vascular inflammation. With DOCK2 knockdown in human vascular ECs, TNF-alpha-mediated VCAM-1 promoter activity was inhibited. The findings from this study suggest the novel concept that DOCK2 promotes the pathogenesis of atherosclerosis by modulating inflammation in vascular ECs. |
